| Autor: |
Yuko, Shiota, Nobuaki, Dobashi, Yuta, Ito, Rika, Hosoba, Hirofumi, Yamauchi, Hiroto, Ishii, Aya, Nakano, Ryoko, Fukushima, Rie, Ohba, Yuichi, Yahagi, Noriko, Usui, Shingo, Yano |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(2) |
| ISSN: |
0485-1439 |
| Popis: |
Primary central nervous system lymphoma (PCNSL) is a rare, aggressive type of non-Hodgkin lymphoma with a poor prognosis and no defined optimal therapeutic strategies. We retrospectively analyzed the survival of six PCNSL patients who were treated with high-dose methotrexate (HDMTX) -based chemotherapy combined with rituximab. The median age at diagnosis was 71 (range, 54-75) years, and the ECOG performance status was ≥3 in four patients. The histopathological findings revealed that all patients had diffuse large B-cell lymphoma. Objective response was obtained in all patients (five, complete response; one, partial response). Three patients had severe non-hematological toxicities: one had pulmonary thromboembolism, one had sepsis, and one developed acute epididymitis. However, each patient recovered and their symptoms could be managed. The median follow-up was 28.8 (range, 13.4-65.5) months. Five patients were still alive and disease-free, and one patient relapsed 62.2 months after the diagnosis. Therefore, the addition of rituximab to HDMTX may improve outcomes. Further clinical investigation is necessary to establish standardized initial therapies for PCNSL, particularly in elderly patients. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
